[go: up one dir, main page]

CA2550186A1 - Composition antivieillissement - Google Patents

Composition antivieillissement Download PDF

Info

Publication number
CA2550186A1
CA2550186A1 CA002550186A CA2550186A CA2550186A1 CA 2550186 A1 CA2550186 A1 CA 2550186A1 CA 002550186 A CA002550186 A CA 002550186A CA 2550186 A CA2550186 A CA 2550186A CA 2550186 A1 CA2550186 A1 CA 2550186A1
Authority
CA
Canada
Prior art keywords
extract
aging
coenzyme
reduced coenzyme
crude drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002550186A
Other languages
English (en)
Inventor
Kenji Fujii
Taizo Kawabe
Hiroshi Kubo
Keiichi Higuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneka Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2550186A1 publication Critical patent/CA2550186A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002550186A 2004-01-08 2005-01-07 Composition antivieillissement Abandoned CA2550186A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004002863 2004-01-08
JP2004-002863 2004-01-08
PCT/JP2005/000430 WO2005065672A1 (fr) 2004-01-08 2005-01-07 Composition antivieillissement

Publications (1)

Publication Number Publication Date
CA2550186A1 true CA2550186A1 (fr) 2005-07-21

Family

ID=34747062

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002550186A Abandoned CA2550186A1 (fr) 2004-01-08 2005-01-07 Composition antivieillissement

Country Status (10)

Country Link
EP (1) EP1701716A1 (fr)
JP (1) JP2007517761A (fr)
KR (1) KR20060134057A (fr)
CN (1) CN1909895A (fr)
AU (1) AU2005204044B2 (fr)
CA (1) CA2550186A1 (fr)
NO (1) NO20063144L (fr)
RU (1) RU2006128735A (fr)
TW (1) TW200526193A (fr)
WO (1) WO2005065672A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007028997A (ja) * 2005-07-27 2007-02-08 Kanebo Seiyaku Kk 生薬エキス配合流動食及びその使用
JPWO2007034852A1 (ja) 2005-09-22 2009-03-26 株式会社カネカ 延命用組成物及び寿命を延長する方法
AU2010302025A1 (en) 2009-09-29 2012-04-19 Shiseido Company, Ltd. Antioxidant composition
US20130195925A1 (en) * 2011-11-03 2013-08-01 Vaskin, Llc Anti aging application and method for treating aging
WO2015163443A1 (fr) * 2014-04-25 2015-10-29 ヤクルトヘルスフーズ株式会社 Agent permettant de retarder l'apparition de symptômes physiques associés au vieillissement
CN104474527B (zh) * 2014-11-24 2015-10-07 南京泛成生物化工有限公司 一种含富硒酵母的组合物及其应用
CN111603552A (zh) * 2020-07-02 2020-09-01 中健智诊(重庆)生物研究院 一种抗衰老组合物及其应用
CN111973477A (zh) * 2020-09-04 2020-11-24 湖南御家化妆品制造有限公司 一种艾地苯醌、微晶纤维素复合载体的制备方法及化妆品

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5366435A (en) * 1976-11-19 1978-06-13 New England Inst Immunologically preventing method for phenomena of aging
EP0969744B1 (fr) * 1997-03-27 2003-05-21 Michael J. Sole Composition nutritionnelle servant a ameliorer la capacite energetique cellulaire
IT1304406B1 (it) * 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6403116B1 (en) * 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US6506915B1 (en) * 2001-06-14 2003-01-14 Daniel David West Synthesis of coenzyme Q10 ubiquinone
TWI329513B (en) * 2001-10-12 2010-09-01 Kaneka Corp Use of reduced coenzyme q for lessening oxidative stress
JP2003135022A (ja) * 2001-10-31 2003-05-13 Crescendo Corporation コエンザイムｑ１０
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
US7438903B2 (en) * 2003-06-06 2008-10-21 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10

Also Published As

Publication number Publication date
CN1909895A (zh) 2007-02-07
KR20060134057A (ko) 2006-12-27
JP2007517761A (ja) 2007-07-05
TW200526193A (en) 2005-08-16
NO20063144L (no) 2006-10-09
WO2005065672A1 (fr) 2005-07-21
AU2005204044A1 (en) 2005-07-21
AU2005204044B2 (en) 2010-07-22
RU2006128735A (ru) 2008-02-20
EP1701716A1 (fr) 2006-09-20

Similar Documents

Publication Publication Date Title
EP2859896B1 (fr) Compositions pharmaceutiques pour le traitement des troubles musculaires
JP2005510509A (ja) 放射線障害の予防、軽減、及び治療用の栄養性サプリメント及びその方法
CN107404927A (zh) 多重补充品组合物
CA2649477A1 (fr) Composition et procede stimulant la bonne sante de l'organisme et l'aspect corporel harmonieux
US20180303891A1 (en) Specific nutritional or therapeutic agent including a mixture of grape and blueberry
TW201622698A (zh) 包含菊花萃取物之組成物與使用其於皮膚增白及皮膚增亮應用之方法
JP6069555B2 (ja) 経口紫外線抵抗性向上剤
CA2907886A1 (fr) Effet neuroprotecteur des carotenoides dans le cerveau
KR20070109981A (ko) 체지방 감소용 조성물
WO2008034316A1 (fr) Préparation de composés capable de reduction rapide de stress oxidatif et son procédé de préparation
EP1938810B1 (fr) Agent d'amelioration pour le syndrome metabolique
EP2836210B1 (fr) Agent permettant d'induire la synthèse de protéines de choc thermique dans des cellules humaines et animales; préparation cosmétique permettant d'améliorer les processus de réparation; préparation cosmétique permettant de réduire les effets secondaires d'interventions de chirurgie esthétique agressives; complément alimentaire
JP2008537678A (ja) リグナン含有組成物
AU2005204044B2 (en) Antiaging composition
US20050154066A1 (en) Antiaging composition
US20100234385A1 (en) Compsition Containing Biopterin and Method for Using The Same
US20100150894A1 (en) Composition for prevention of cancer
JPH07330593A (ja) 疲労改善剤
KR20200063772A (ko) 진세노사이드 Re를 포함하는 거저리 유충 추출물을 유효성분으로 포함하는 항염증용 조성물
TW200803828A (en) Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent
KR101719015B1 (ko) 프루네틴을 유효성분으로 함유하는 비만 또는 대사성 질환의 예방 또는 치료용 약학적 조성물
WO2007034852A1 (fr) Composition destinée à prolonger la vie et procédé destiné à prolonger la vie
KR20190053309A (ko) 쌀겨 추출물을 함유하는 피부 개선용 건강기능식품
JP2002220333A (ja) 経口美白剤
WO2021240461A1 (fr) Compléments alimentaires

Legal Events

Date Code Title Description
FZDE Discontinued